GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shandong Sinobioway Biomedicine Co Ltd (SZSE:002581) » Definitions » Construction In Progress

Shandong Sinobioway Biomedicine Co (SZSE:002581) Construction In Progress : ¥21.1 Mil (As of Sep. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Shandong Sinobioway Biomedicine Co Construction In Progress?

Shandong Sinobioway Biomedicine Co's quarterly construction in progress increased from Mar. 2024 (¥20.9 Mil) to Jun. 2024 (¥21.0 Mil) and increased from Jun. 2024 (¥21.0 Mil) to Sep. 2024 (¥21.1 Mil).

Shandong Sinobioway Biomedicine Co's annual construction in progress increased from Dec. 2021 (¥64.9 Mil) to Dec. 2022 (¥91.4 Mil) but then declined from Dec. 2022 (¥91.4 Mil) to Dec. 2023 (¥22.2 Mil).


Shandong Sinobioway Biomedicine Co Construction In Progress Historical Data

The historical data trend for Shandong Sinobioway Biomedicine Co's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Sinobioway Biomedicine Co Construction In Progress Chart

Shandong Sinobioway Biomedicine Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 347.29 353.63 64.86 91.43 22.17

Shandong Sinobioway Biomedicine Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 80.18 22.17 20.89 21.02 21.06

Shandong Sinobioway Biomedicine Co Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.


Shandong Sinobioway Biomedicine Co Business Description

Traded in Other Exchanges
N/A
Address
No.18, Chaoyang Road, Zhangdian District, Zibo City, Shandong, CHN, 255068
Shandong Sinobioway Biomedicine Co Ltd is engaged in the research, development, manufacturing and marketing of trimethyl orthoformate and triethyl orthoformate.
Executives
He Xun Executives
Yang Xiao Min Director
Yu Tong Jie Executives
Yan Li Director

Shandong Sinobioway Biomedicine Co Headlines

No Headlines